Aarkstore - OncoHealth Corporation - Product Pipeline Analysis, 2014 Update
Summary
OncoHealth Corporation (OncoHealth) is a pharmaceutical company. The company offers protein biomarker diagnostics and screening products for detection of oncoproteins. Its products include Direct E6/E7 whole cell ELISA and Direct E6/E7 flow cytometry assay. OncoHealth’s Direct E6/E7 whole cell ELISA is a test kit used for detection of HPV E6 and E7 oncoproteins in liquid-based cytology samples by ELISA. The company’s Direct E6/E7 flow cytometry assay is used for the detection of HPV E6 and E7 oncoproteins in liquid based cytology samples by flow cytometry. Its products serve the needs of cervical cancer screening and diagnostic market. OncoHealth is headquartered in San Jose, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company OncoHealth Corporation
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing...